Abiraterone for the treatment of metastatic prostate cancer without previous chemotherapy

被引：0
|
作者：
Laffman-Johnson, Elise
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2013年 / 93卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [31] Use and security analysis of abiraterone in metastatic prostate cancer
    Dolores Alvarado-Fernandez, Maria
    Vazquez-Real, Miguel
    Marcos Rodriguez, Jose Antonio
    Santana Martinez, Sara
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 280 - 280
  • [32] Abiraterone acetate in the treatment of prostate cancer
    Thakur, Abhimanyu
    Roy, Aishwarya
    Ghosh, Arijit
    Chhabra, Mohit
    Banerjee, Sugato
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 101 : 211 - 218
  • [33] Re: Abiraterone and Increased Survival in Metastatic Prostate Cancer
    Cheetham, Philippa J.
    Petrylak, Daniel P.
    EUROPEAN UROLOGY, 2012, 61 (04) : 850 - 850
  • [34] Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate
    Petrioli, Roberto
    Francini, Edoardo
    Laera, Letizia
    Fiaschi, Anna Ida
    Ponchietti, Roberto
    Roviello, Giandomenico
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (03) : 439 - 445
  • [35] Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate
    Roberto Petrioli
    Edoardo Francini
    Letizia Laera
    Anna Ida Fiaschi
    Roberto Ponchietti
    Giandomenico Roviello
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 439 - 445
  • [36] Use of abiraterone acetate in advanced metastatic prostate cancer
    Marquez Fernandez, E.
    Marmesat Rodas, B.
    Quesada Sanz, M. P.
    Gallego Galisteo, M.
    Ramos Baez, J. J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 994 - 994
  • [37] Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
    de Wit, Ronald
    de Bono, Johann
    Sternberg, Cora N.
    Fizazi, Karim
    Tombal, Bertrand
    Wuelfing, Christian
    Kramer, Gero
    Eymard, Jean-Christophe
    Bamias, Aristotelis
    Carles, Joan
    Iacovelli, Roberto
    Melichar, Bohuslav
    Sverrisdottir, Asgerdur
    Theodore, Christine
    Feyerabend, Susan
    Helissey, Carole
    Ozatilgan, Ayse
    Geffriaud-Ricouard, Christine
    Castellano, Daniel
    de Wit, Ronald
    de Bono, Johann
    Sternberg, Cora N.
    Fizazi, Karim
    Tombal, Bertrand
    Wulfing, Christian
    Kramer, Gero
    Eymard, Jean-Christophe
    Bamias, Aristotelis
    Carles, Joan
    Iacovelli, Roberto
    Melichar, Bohuslav
    Sverrisdottir, Asgerour
    Theodore, Christine
    Feyerabend, Susan
    Helissey, Carole
    Ozatilgan, Ayse
    Geffriaud-Ricouard, Christine
    Castellano, Daniel
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (26): : 2506 - 2518
  • [38] What do we know about treatment sequencing of abiraterone, enzalutamide, and chemotherapy in metastatic castration-resistant prostate cancer?
    Lebdai, Souhil
    Basset, Victor
    Branchereau, Julien
    de La Taille, Alexandre
    Flamand, Vincent
    Lebret, Thierry
    Murez, Thibaut
    Neuzillet, Yann
    Ploussard, Guillaume
    Audenet, Francois
    WORLD JOURNAL OF UROLOGY, 2016, 34 (05) : 617 - 624
  • [39] Pharmacoeconomic aspects of using enzalutamide and abiraterone for treatment of chemotherapy-naive patients with metastatic castration-resistant prostate cancer
    Avxentyev, N. A.
    Frolov, M. Yu
    Makarova, Yu, V
    ONKOUROLOGIYA, 2019, 15 (02): : 86 - 99
  • [40] Impact of previous local treatment for prostate cancer on subsequent metastatic disease
    Thompson, IM
    Tangen, C
    Basler, J
    Crawford, ED
    JOURNAL OF UROLOGY, 2002, 168 (03): : 1008 - 1012
12345